局所止血剤世界市場の発展状況と動向 2024-2030

QY Research > レポート一覧 > 薬品及びサプリメント > 局所止血剤世界市場の発展状況と動向 2024-2030

英文タイトル： Global Topical Hemostatic Agents Market Insights, Forecast to 2030

レポートID：278248
発表時期：2024-04-25
訪問回数：141
ページ数：111
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：134
レポートカテゴリ：薬品及びサプリメント

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、局所止血剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に局所止血剤市場を分類しています。

本レポートでは世界の局所止血剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Ethicon、Pfizer、Baxter International、C. R. Bard、The Medicines Company、Anika Therapeutics、Advanced Medical Solutions、Integra LifeSciences、B Braun Melsungen、Gelita Medical、Equimedical、Vascular Solutions、Marine Polymer Technologies

レポートは局所止血剤の主要生産者を調査し、主要地域や国の消費状況も提供します。局所止血剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント：
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others

用途別の市場セグメント：
Hospitals
Surgical Centers
Nursing Homes

本レポートの詳細内容
本レポートは、世界の局所止血剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて局所止血剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の局所止血剤生産量、成長率、市場シェアを調査している。

二. 消費面では、局所止血剤の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの局所止血剤売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の局所止血剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本局所止血剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

第1章：局所止血剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章：局所止血剤の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける局所止血剤の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章局所止血剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：局所止血剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：局所止血剤の主要メーカーの概要を提供し、製品の説明と仕様、局所止血剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：局所止血剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

概要

Topical hemostatic agents are important adjuncts to reduce blood loss after cardiac surgery and can have a role in reducing both “surgical” and “nonsurgical bleeding.” There are many topical hemostatic agents to choose from, and with several new products in this field being approved for use in the last few years,
The global Topical Hemostatic Agents market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Topical Hemostatic Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Topical Hemostatic Agents, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Topical Hemostatic Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Topical Hemostatic Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Topical Hemostatic Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Topical Hemostatic Agents sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences and B Braun Melsungen, etc.
Market Segmentation
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies

Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others

Segment by Application
Hospitals
Surgical Centers
Nursing Homes

Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Topical Hemostatic Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Topical Hemostatic Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Topical Hemostatic Agents sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

総目録

1 Study Coverage
1.1 Topical Hemostatic Agents Product Introduction
1.2 Market by Type
1.2.1 Global Topical Hemostatic Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Market by Application
1.3.1 Global Topical Hemostatic Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Topical Hemostatic Agents Sales Estimates and Forecasts 2019-2030
2.2 Global Topical Hemostatic Agents Revenue by Region
2.2.1 Global Topical Hemostatic Agents Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Topical Hemostatic Agents Revenue by Region (2019-2024)
2.2.3 Global Topical Hemostatic Agents Revenue by Region (2025-2030)
2.2.4 Global Topical Hemostatic Agents Revenue Market Share by Region (2019-2030)
2.3 Global Topical Hemostatic Agents Sales Estimates and Forecasts 2019-2030
2.4 Global Topical Hemostatic Agents Sales by Region
2.4.1 Global Topical Hemostatic Agents Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Topical Hemostatic Agents Sales by Region (2019-2024)
2.4.3 Global Topical Hemostatic Agents Sales by Region (2025-2030)
2.4.4 Global Topical Hemostatic Agents Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 Competition by Manufactures
3.1 Global Topical Hemostatic Agents Sales by Manufacturers
3.1.1 Global Topical Hemostatic Agents Sales by Manufacturers (2019-2024)
3.1.2 Global Topical Hemostatic Agents Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Topical Hemostatic Agents in 2023
3.2 Global Topical Hemostatic Agents Revenue by Manufacturers
3.2.1 Global Topical Hemostatic Agents Revenue by Manufacturers (2019-2024)
3.2.2 Global Topical Hemostatic Agents Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Topical Hemostatic Agents Revenue in 2023
3.3 Global Key Players of Topical Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Topical Hemostatic Agents Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Topical Hemostatic Agents, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Topical Hemostatic Agents, Product Offered and Application
3.8 Global Key Manufacturers of Topical Hemostatic Agents, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Topical Hemostatic Agents Sales by Type
4.1.1 Global Topical Hemostatic Agents Historical Sales by Type (2019-2024)
4.1.2 Global Topical Hemostatic Agents Forecasted Sales by Type (2025-2030)
4.1.3 Global Topical Hemostatic Agents Sales Market Share by Type (2019-2030)
4.2 Global Topical Hemostatic Agents Revenue by Type
4.2.1 Global Topical Hemostatic Agents Historical Revenue by Type (2019-2024)
4.2.2 Global Topical Hemostatic Agents Forecasted Revenue by Type (2025-2030)
4.2.3 Global Topical Hemostatic Agents Revenue Market Share by Type (2019-2030)
4.3 Global Topical Hemostatic Agents Price by Type
4.3.1 Global Topical Hemostatic Agents Price by Type (2019-2024)
4.3.2 Global Topical Hemostatic Agents Price Forecast by Type (2025-2030)

5 Market Size by Application
5.1 Global Topical Hemostatic Agents Sales by Application
5.1.1 Global Topical Hemostatic Agents Historical Sales by Application (2019-2024)
5.1.2 Global Topical Hemostatic Agents Forecasted Sales by Application (2025-2030)
5.1.3 Global Topical Hemostatic Agents Sales Market Share by Application (2019-2030)
5.2 Global Topical Hemostatic Agents Revenue by Application
5.2.1 Global Topical Hemostatic Agents Historical Revenue by Application (2019-2024)
5.2.2 Global Topical Hemostatic Agents Forecasted Revenue by Application (2025-2030)
5.2.3 Global Topical Hemostatic Agents Revenue Market Share by Application (2019-2030)
5.3 Global Topical Hemostatic Agents Price by Application
5.3.1 Global Topical Hemostatic Agents Price by Application (2019-2024)
5.3.2 Global Topical Hemostatic Agents Price Forecast by Application (2025-2030)

6 US & Canada
6.1 US & Canada Topical Hemostatic Agents Market Size by Type
6.1.1 US & Canada Topical Hemostatic Agents Sales by Type (2019-2030)
6.1.2 US & Canada Topical Hemostatic Agents Revenue by Type (2019-2030)
6.2 US & Canada Topical Hemostatic Agents Market Size by Application
6.2.1 US & Canada Topical Hemostatic Agents Sales by Application (2019-2030)
6.2.2 US & Canada Topical Hemostatic Agents Revenue by Application (2019-2030)
6.3 US & Canada Topical Hemostatic Agents Market Size by Country
6.3.1 US & Canada Topical Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Topical Hemostatic Agents Sales by Country (2019-2030)
6.3.3 US & Canada Topical Hemostatic Agents Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada

7 Europe
7.1 Europe Topical Hemostatic Agents Market Size by Type
7.1.1 Europe Topical Hemostatic Agents Sales by Type (2019-2030)
7.1.2 Europe Topical Hemostatic Agents Revenue by Type (2019-2030)
7.2 Europe Topical Hemostatic Agents Market Size by Application
7.2.1 Europe Topical Hemostatic Agents Sales by Application (2019-2030)
7.2.2 Europe Topical Hemostatic Agents Revenue by Application (2019-2030)
7.3 Europe Topical Hemostatic Agents Market Size by Country
7.3.1 Europe Topical Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Topical Hemostatic Agents Sales by Country (2019-2030)
7.3.3 Europe Topical Hemostatic Agents Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia

8 China
8.1 China Topical Hemostatic Agents Market Size
8.1.1 China Topical Hemostatic Agents Sales (2019-2030)
8.1.2 China Topical Hemostatic Agents Revenue (2019-2030)
8.2 China Topical Hemostatic Agents Market Size by Application
8.2.1 China Topical Hemostatic Agents Sales by Application (2019-2030)
8.2.2 China Topical Hemostatic Agents Revenue by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Topical Hemostatic Agents Market Size by Type
9.1.1 Asia Topical Hemostatic Agents Sales by Type (2019-2030)
9.1.2 Asia Topical Hemostatic Agents Revenue by Type (2019-2030)
9.2 Asia Topical Hemostatic Agents Market Size by Application
9.2.1 Asia Topical Hemostatic Agents Sales by Application (2019-2030)
9.2.2 Asia Topical Hemostatic Agents Revenue by Application (2019-2030)
9.3 Asia Topical Hemostatic Agents Sales by Region
9.3.1 Asia Topical Hemostatic Agents Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Topical Hemostatic Agents Revenue by Region (2019-2030)
9.3.3 Asia Topical Hemostatic Agents Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India

10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Topical Hemostatic Agents Market Size by Type
10.1.1 Middle East, Africa and Latin America Topical Hemostatic Agents Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Topical Hemostatic Agents Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Topical Hemostatic Agents Market Size by Application
10.2.1 Middle East, Africa and Latin America Topical Hemostatic Agents Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Topical Hemostatic Agents Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Topical Hemostatic Agents Sales by Country
10.3.1 Middle East, Africa and Latin America Topical Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Topical Hemostatic Agents Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Topical Hemostatic Agents Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries

11 Company Profiles
11.1 Ethicon
11.1.1 Ethicon Company Information
11.1.2 Ethicon Overview
11.1.3 Ethicon Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Ethicon Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ethicon Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Pfizer Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Baxter International
11.3.1 Baxter International Company Information
11.3.2 Baxter International Overview
11.3.3 Baxter International Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Baxter International Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Baxter International Recent Developments
11.4 C. R. Bard
11.4.1 C. R. Bard Company Information
11.4.2 C. R. Bard Overview
11.4.3 C. R. Bard Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 C. R. Bard Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 C. R. Bard Recent Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Company Information
11.5.2 The Medicines Company Overview
11.5.3 The Medicines Company Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 The Medicines Company Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 The Medicines Company Recent Developments
11.6 Anika Therapeutics
11.6.1 Anika Therapeutics Company Information
11.6.2 Anika Therapeutics Overview
11.6.3 Anika Therapeutics Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Anika Therapeutics Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Anika Therapeutics Recent Developments
11.7 Advanced Medical Solutions
11.7.1 Advanced Medical Solutions Company Information
11.7.2 Advanced Medical Solutions Overview
11.7.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Advanced Medical Solutions Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Advanced Medical Solutions Recent Developments
11.8 Integra LifeSciences
11.8.1 Integra LifeSciences Company Information
11.8.2 Integra LifeSciences Overview
11.8.3 Integra LifeSciences Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Integra LifeSciences Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Integra LifeSciences Recent Developments
11.9 B Braun Melsungen
11.9.1 B Braun Melsungen Company Information
11.9.2 B Braun Melsungen Overview
11.9.3 B Braun Melsungen Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 B Braun Melsungen Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 B Braun Melsungen Recent Developments
11.10 Gelita Medical
11.10.1 Gelita Medical Company Information
11.10.2 Gelita Medical Overview
11.10.3 Gelita Medical Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Gelita Medical Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Gelita Medical Recent Developments
11.11 Equimedical
11.11.1 Equimedical Company Information
11.11.2 Equimedical Overview
11.11.3 Equimedical Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Equimedical Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Equimedical Recent Developments
11.12 Vascular Solutions
11.12.1 Vascular Solutions Company Information
11.12.2 Vascular Solutions Overview
11.12.3 Vascular Solutions Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Vascular Solutions Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Vascular Solutions Recent Developments
11.13 Marine Polymer Technologies
11.13.1 Marine Polymer Technologies Company Information
11.13.2 Marine Polymer Technologies Overview
11.13.3 Marine Polymer Technologies Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Marine Polymer Technologies Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Marine Polymer Technologies Recent Developments

12 Industry Chain and Sales Channels Analysis
12.1 Topical Hemostatic Agents Industry Chain Analysis
12.2 Topical Hemostatic Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Topical Hemostatic Agents Production Mode & Process
12.4 Topical Hemostatic Agents Sales and Marketing
12.4.1 Topical Hemostatic Agents Sales Channels
12.4.2 Topical Hemostatic Agents Distributors
12.5 Topical Hemostatic Agents Customers

13 Market Dynamics
13.1 Topical Hemostatic Agents Industry Trends
13.2 Topical Hemostatic Agents Market Drivers
13.3 Topical Hemostatic Agents Market Challenges
13.4 Topical Hemostatic Agents Market Restraints

14 Key Findings in The Global Topical Hemostatic Agents Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

表と図のリスト

List of Tables
    Table 1. Global Topical Hemostatic Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Gelation Sponge
    Table 3. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats
    Table 4. Major Manufacturers of Others
    Table 5. Global Topical Hemostatic Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Topical Hemostatic Agents Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Topical Hemostatic Agents Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Topical Hemostatic Agents Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Topical Hemostatic Agents Revenue Market Share by Region (2019-2024)
    Table 10. Global Topical Hemostatic Agents Revenue Market Share by Region (2025-2030)
    Table 11. Global Topical Hemostatic Agents Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Topical Hemostatic Agents Sales by Region (2019-2024) & (K Units)
    Table 13. Global Topical Hemostatic Agents Sales by Region (2025-2030) & (K Units)
    Table 14. Global Topical Hemostatic Agents Sales Market Share by Region (2019-2024)
    Table 15. Global Topical Hemostatic Agents Sales Market Share by Region (2025-2030)
    Table 16. Global Topical Hemostatic Agents Sales by Manufacturers (2019-2024) & (K Units)
    Table 17. Global Topical Hemostatic Agents Sales Share by Manufacturers (2019-2024)
    Table 18. Global Topical Hemostatic Agents Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Topical Hemostatic Agents Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Topical Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Topical Hemostatic Agents Price by Manufacturers 2019-2024 (USD/Unit)
    Table 22. Global Topical Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Topical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topical Hemostatic Agents as of 2023)
    Table 24. Global Key Manufacturers of Topical Hemostatic Agents, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Topical Hemostatic Agents, Product Offered and Application
    Table 26. Global Key Manufacturers of Topical Hemostatic Agents, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Topical Hemostatic Agents Sales by Type (2019-2024) & (K Units)
    Table 29. Global Topical Hemostatic Agents Sales by Type (2025-2030) & (K Units)
    Table 30. Global Topical Hemostatic Agents Sales Share by Type (2019-2024)
    Table 31. Global Topical Hemostatic Agents Sales Share by Type (2025-2030)
    Table 32. Global Topical Hemostatic Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Topical Hemostatic Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Topical Hemostatic Agents Revenue Share by Type (2019-2024)
    Table 35. Global Topical Hemostatic Agents Revenue Share by Type (2025-2030)
    Table 36. Topical Hemostatic Agents Price by Type (2019-2024) & (USD/Unit)
    Table 37. Global Topical Hemostatic Agents Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 38. Global Topical Hemostatic Agents Sales by Application (2019-2024) & (K Units)
    Table 39. Global Topical Hemostatic Agents Sales by Application (2025-2030) & (K Units)
    Table 40. Global Topical Hemostatic Agents Sales Share by Application (2019-2024)
    Table 41. Global Topical Hemostatic Agents Sales Share by Application (2025-2030)
    Table 42. Global Topical Hemostatic Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Topical Hemostatic Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Topical Hemostatic Agents Revenue Share by Application (2019-2024)
    Table 45. Global Topical Hemostatic Agents Revenue Share by Application (2025-2030)
    Table 46. Topical Hemostatic Agents Price by Application (2019-2024) & (USD/Unit)
    Table 47. Global Topical Hemostatic Agents Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 48. US & Canada Topical Hemostatic Agents Sales by Type (2019-2024) & (K Units)
    Table 49. US & Canada Topical Hemostatic Agents Sales by Type (2025-2030) & (K Units)
    Table 50. US & Canada Topical Hemostatic Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Topical Hemostatic Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Topical Hemostatic Agents Sales by Application (2019-2024) & (K Units)
    Table 53. US & Canada Topical Hemostatic Agents Sales by Application (2025-2030) & (K Units)
    Table 54. US & Canada Topical Hemostatic Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Topical Hemostatic Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Topical Hemostatic Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Topical Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Topical Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Topical Hemostatic Agents Sales by Country (2019-2024) & (K Units)
    Table 60. US & Canada Topical Hemostatic Agents Sales by Country (2025-2030) & (K Units)
    Table 61. Europe Topical Hemostatic Agents Sales by Type (2019-2024) & (K Units)
    Table 62. Europe Topical Hemostatic Agents Sales by Type (2025-2030) & (K Units)
    Table 63. Europe Topical Hemostatic Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Topical Hemostatic Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Topical Hemostatic Agents Sales by Application (2019-2024) & (K Units)
    Table 66. Europe Topical Hemostatic Agents Sales by Application (2025-2030) & (K Units)
    Table 67. Europe Topical Hemostatic Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Topical Hemostatic Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Topical Hemostatic Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Topical Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Topical Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Topical Hemostatic Agents Sales by Country (2019-2024) & (K Units)
    Table 73. Europe Topical Hemostatic Agents Sales by Country (2025-2030) & (K Units)
    Table 74. China Topical Hemostatic Agents Sales by Type (2019-2024) & (K Units)
    Table 75. China Topical Hemostatic Agents Sales by Type (2025-2030) & (K Units)
    Table 76. China Topical Hemostatic Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Topical Hemostatic Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Topical Hemostatic Agents Sales by Application (2019-2024) & (K Units)
    Table 79. China Topical Hemostatic Agents Sales by Application (2025-2030) & (K Units)
    Table 80. China Topical Hemostatic Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Topical Hemostatic Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Topical Hemostatic Agents Sales by Type (2019-2024) & (K Units)
    Table 83. Asia Topical Hemostatic Agents Sales by Type (2025-2030) & (K Units)
    Table 84. Asia Topical Hemostatic Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Topical Hemostatic Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Topical Hemostatic Agents Sales by Application (2019-2024) & (K Units)
    Table 87. Asia Topical Hemostatic Agents Sales by Application (2025-2030) & (K Units)
    Table 88. Asia Topical Hemostatic Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Topical Hemostatic Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Topical Hemostatic Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Topical Hemostatic Agents Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Topical Hemostatic Agents Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Topical Hemostatic Agents Sales by Region (2019-2024) & (K Units)
    Table 94. Asia Topical Hemostatic Agents Sales by Region (2025-2030) & (K Units)
    Table 95. Middle East, Africa and Latin America Topical Hemostatic Agents Sales by Type (2019-2024) & (K Units)
    Table 96. Middle East, Africa and Latin America Topical Hemostatic Agents Sales by Type (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Topical Hemostatic Agents Sales by Application (2019-2024) & (K Units)
    Table 100. Middle East, Africa and Latin America Topical Hemostatic Agents Sales by Application (2025-2030) & (K Units)
    Table 101. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Topical Hemostatic Agents Sales by Country (2019-2024) & (K Units)
    Table 107. Middle East, Africa and Latin America Topical Hemostatic Agents Sales by Country (2025-2030) & (K Units)
    Table 108. Ethicon Company Information
    Table 109. Ethicon Description and Major Businesses
    Table 110. Ethicon Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 111. Ethicon Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Ethicon Recent Developments
    Table 113. Pfizer Company Information
    Table 114. Pfizer Description and Major Businesses
    Table 115. Pfizer Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 116. Pfizer Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Pfizer Recent Developments
    Table 118. Baxter International Company Information
    Table 119. Baxter International Description and Major Businesses
    Table 120. Baxter International Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 121. Baxter International Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Baxter International Recent Developments
    Table 123. C. R. Bard Company Information
    Table 124. C. R. Bard Description and Major Businesses
    Table 125. C. R. Bard Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 126. C. R. Bard Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. C. R. Bard Recent Developments
    Table 128. The Medicines Company Company Information
    Table 129. The Medicines Company Description and Major Businesses
    Table 130. The Medicines Company Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 131. The Medicines Company Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. The Medicines Company Recent Developments
    Table 133. Anika Therapeutics Company Information
    Table 134. Anika Therapeutics Description and Major Businesses
    Table 135. Anika Therapeutics Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 136. Anika Therapeutics Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Anika Therapeutics Recent Developments
    Table 138. Advanced Medical Solutions Company Information
    Table 139. Advanced Medical Solutions Description and Major Businesses
    Table 140. Advanced Medical Solutions Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 141. Advanced Medical Solutions Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Advanced Medical Solutions Recent Developments
    Table 143. Integra LifeSciences Company Information
    Table 144. Integra LifeSciences Description and Major Businesses
    Table 145. Integra LifeSciences Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 146. Integra LifeSciences Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Integra LifeSciences Recent Developments
    Table 148. B Braun Melsungen Company Information
    Table 149. B Braun Melsungen Description and Major Businesses
    Table 150. B Braun Melsungen Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 151. B Braun Melsungen Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. B Braun Melsungen Recent Developments
    Table 153. Gelita Medical Company Information
    Table 154. Gelita Medical Description and Major Businesses
    Table 155. Gelita Medical Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 156. Gelita Medical Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Gelita Medical Recent Developments
    Table 158. Equimedical Company Information
    Table 159. Equimedical Description and Major Businesses
    Table 160. Equimedical Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 161. Equimedical Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Equimedical Recent Developments
    Table 163. Vascular Solutions Company Information
    Table 164. Vascular Solutions Description and Major Businesses
    Table 165. Vascular Solutions Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 166. Vascular Solutions Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Vascular Solutions Recent Developments
    Table 168. Marine Polymer Technologies Company Information
    Table 169. Marine Polymer Technologies Description and Major Businesses
    Table 170. Marine Polymer Technologies Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 171. Marine Polymer Technologies Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Marine Polymer Technologies Recent Developments
    Table 173. Key Raw Materials Lists
    Table 174. Raw Materials Key Suppliers Lists
    Table 175. Topical Hemostatic Agents Distributors List
    Table 176. Topical Hemostatic Agents Customers List
    Table 177. Topical Hemostatic Agents Market Trends
    Table 178. Topical Hemostatic Agents Market Drivers
    Table 179. Topical Hemostatic Agents Market Challenges
    Table 180. Topical Hemostatic Agents Market Restraints
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Topical Hemostatic Agents Product Picture
    Figure 2. Global Topical Hemostatic Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Topical Hemostatic Agents Market Share by Type in 2023 & 2030
    Figure 4. Gelation Sponge Product Picture
    Figure 5. Oxidized Regenerated Cellulose Based Hemostats Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Topical Hemostatic Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Topical Hemostatic Agents Market Share by Application in 2023 & 2030
    Figure 9. Hospitals
    Figure 10. Surgical Centers
    Figure 11. Nursing Homes
    Figure 12. Topical Hemostatic Agents Report Years Considered
    Figure 13. Global Topical Hemostatic Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Topical Hemostatic Agents Revenue 2019-2030 (US$ Million)
    Figure 15. Global Topical Hemostatic Agents Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Topical Hemostatic Agents Revenue Market Share by Region (2019-2030)
    Figure 17. Global Topical Hemostatic Agents Sales 2019-2030 ((K Units)
    Figure 18. Global Topical Hemostatic Agents Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Topical Hemostatic Agents Sales YoY (2019-2030) & (K Units)
    Figure 20. US & Canada Topical Hemostatic Agents Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Topical Hemostatic Agents Sales YoY (2019-2030) & (K Units)
    Figure 22. Europe Topical Hemostatic Agents Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Topical Hemostatic Agents Sales YoY (2019-2030) & (K Units)
    Figure 24. China Topical Hemostatic Agents Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Topical Hemostatic Agents Sales YoY (2019-2030) & (K Units)
    Figure 26. Asia (excluding China) Topical Hemostatic Agents Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Topical Hemostatic Agents Sales YoY (2019-2030) & (K Units)
    Figure 28. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Topical Hemostatic Agents Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Topical Hemostatic Agents in the World: Market Share by Topical Hemostatic Agents Revenue in 2023
    Figure 31. Global Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Topical Hemostatic Agents Sales Market Share by Type (2019-2030)
    Figure 33. Global Topical Hemostatic Agents Revenue Market Share by Type (2019-2030)
    Figure 34. Global Topical Hemostatic Agents Sales Market Share by Application (2019-2030)
    Figure 35. Global Topical Hemostatic Agents Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Topical Hemostatic Agents Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Topical Hemostatic Agents Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Topical Hemostatic Agents Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Topical Hemostatic Agents Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Topical Hemostatic Agents Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Topical Hemostatic Agents Sales Share by Country (2019-2030)
    Figure 42. U.S. Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Topical Hemostatic Agents Sales Market Share by Type (2019-2030)
    Figure 45. Europe Topical Hemostatic Agents Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Topical Hemostatic Agents Sales Market Share by Application (2019-2030)
    Figure 47. Europe Topical Hemostatic Agents Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Topical Hemostatic Agents Revenue Share by Country (2019-2030)
    Figure 49. Europe Topical Hemostatic Agents Sales Share by Country (2019-2030)
    Figure 50. Germany Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 51. France Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 55. China Topical Hemostatic Agents Sales Market Share by Type (2019-2030)
    Figure 56. China Topical Hemostatic Agents Revenue Market Share by Type (2019-2030)
    Figure 57. China Topical Hemostatic Agents Sales Market Share by Application (2019-2030)
    Figure 58. China Topical Hemostatic Agents Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Topical Hemostatic Agents Sales Market Share by Type (2019-2030)
    Figure 60. Asia Topical Hemostatic Agents Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Topical Hemostatic Agents Sales Market Share by Application (2019-2030)
    Figure 62. Asia Topical Hemostatic Agents Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Topical Hemostatic Agents Revenue Share by Region (2019-2030)
    Figure 64. Asia Topical Hemostatic Agents Sales Share by Region (2019-2030)
    Figure 65. Japan Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 69. India Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Topical Hemostatic Agents Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Topical Hemostatic Agents Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Topical Hemostatic Agents Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Topical Hemostatic Agents Sales Share by Country (2019-2030)
    Figure 76. Brazil Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Topical Hemostatic Agents Revenue (2019-2030) & (US$ Million)
    Figure 81. Topical Hemostatic Agents Value Chain
    Figure 82. Topical Hemostatic Agents Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed

産業カテゴリー